ARALEZ PHARMACEUTICALS INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
ARALEZ PHARMACEUTICALS INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of -$17.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-09
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was -$17.00K, a 100.01% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $200.52M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $831.00K, a 2274.29% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was -$3.71M, a 495.21% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $346.26M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was -$1.22M, a 116.44% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $7.39M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$17.00K 10-Q · filed 2017-05-09 | $200.50M derived: sum of 2 quarters · filed 2017-05-09 | $201.33M derived: sum of 3 quarters · filed 2017-05-09 | $197.62M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | $200.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $201.35M derived: sum of 2 quarters · filed 2017-03-13 | $197.64M derived: sum of 3 quarters · filed 2017-03-13 | $346.26M 10-K · filed 2017-03-13 |
| 2016-09-30 | $831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$2.88M derived: sum of 2 quarters · filed 2016-11-08 | $145.74M 10-Q · filed 2016-11-08 | $143.44M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $144.91M 10-Q · filed 2016-08-09 | $142.61M derived: sum of 3 quarters · filed 2017-05-09 | $142.64M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-03-31 | $148.63M 10-Q · filed 2017-05-09 | $146.32M derived: sum of 2 quarters · filed 2017-05-09 | $146.36M derived: sum of 3 quarters · filed 2017-05-09 | $147.30M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$2.27M derived: sum of 2 quarters · filed 2017-03-13 | -$1.33M derived: sum of 3 quarters · filed 2017-03-13 | -$1.22M 10-K · filed 2017-03-13 |
| 2015-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $975.00K derived: sum of 2 quarters · filed 2016-11-08 | $1.09M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $940.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.05M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $114.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $7.39M 10-K · filed 2017-03-13 |